VS
stockvs
Go to ScreenerHub
ABBV

ABBV vs NVS

NVS

In the past 12 months, NVS returned +38% while ABBV gained 3%.

ABBV
ABBV

AbbVie Inc.

$221.45
-4.9%(1M)
Market Cap391.6B
Healthcare
Drug Manufacturers - General
USA
P/E Ratio95.64
ROE-3.6%
P/B Ratio-123.60
Dividend Yield2.9%
NVS
NVS

Novartis AG

$154.87
-6.8%(1M)
Market Cap299.4B
Healthcare
Drug Manufacturers - General
CH
P/E Ratio21.34
ROE32.8%
P/B Ratio6.48
Dividend Yield3.0%
Performance Comparison

Historical returns across multiple timeframes

NVS leads 5/8
ABBV

ABBV

AbbVie Inc.

+3.3%

1Y Return

NVS

NVS

Novartis AG

+38.0%

1Y Return

ABBV
ABBV
NVS
NVS

Short Term

1M-6M

NVS
+11.3%

Medium Term

YTD-1Y

NVS
+24.9%

Long Term

3Y-10Y

ABBV
+145.2%

Valuation

Compare price multiples and valuation ratios

ABBV: 1NVS: 4
MetricABBVNVSWinner
P/E Ratio

Price to earnings ratio

95.6421.34NVS
Forward P/E

Forward price to earnings ratio

0.000.00Tie
P/S Ratio

Price to sales ratio

6.565.30NVS
P/B Ratio

Price to book ratio

-123.606.48ABBV
P/FCF Ratio

Price to free cash flow ratio

21.4617.78NVS
EV/EBITDA

Enterprise value to EBITDA

16.4114.15NVS
PEG Ratio

Price/earnings to growth ratio

0.000.00Tie

Profitability

Compare profit margins and returns on capital

ABBV: 0NVS: 6
MetricABBVNVSWinner
Gross Margin

Gross profit margin

73.3%75.7%NVS
Operating Margin

Operating profit margin

26.7%31.2%NVS
Net Margin

Net profit margin

6.9%24.9%NVS
ROE

Return on equity

-3.6%32.8%NVS
ROA

Return on assets

3.2%12.1%NVS
ROIC

Return on invested capital

10.6%16.0%NVS

Growth

Compare revenue and earnings growth rates

ABBV: 2NVS: 4
MetricABBVNVSWinner
Revenue Growth (YoY)

Year-over-year revenue growth

8.6%6.0%ABBV
Revenue Growth (3Y)

3-year revenue CAGR

1.8%8.0%NVS
Revenue Growth (5Y)

5-year revenue CAGR

6.0%1.9%ABBV
EPS Growth (YoY)

Year-over-year EPS growth

-1.3%22.5%NVS
EPS Growth (3Y)

3-year EPS CAGR

-29.1%31.4%NVS
EPS Growth (5Y)

5-year EPS CAGR

-2.8%15.4%NVS

Balance Sheet & Risk

Compare financial stability and debt levels

ABBV: 2NVS: 3
MetricABBVNVSWinner
Debt/Equity

Debt to equity ratio

-21.060.80ABBV
Current Ratio

Current assets to current liabilities

0.671.12NVS
Quick Ratio

Quick assets to current liabilities

0.560.89NVS
Interest Coverage

EBIT to interest expense

5.7715.13NVS
Beta

Stock volatility vs market

0.330.50ABBV
Summary
NVS wins 4-0

Valuation

NVS

Profitability

NVS

Growth

NVS

Balance Sheet

NVS

NVS is more attractively valued. NVS shows stronger profitability. NVS demonstrates better growth. NVS has a stronger balance sheet.

Take Your Analysis Further

Dive deeper into ABBV and NVS with Screenerhub. Access advanced screening tools, set up monitoring alerts, and discover more investment opportunities.

Embed This Comparison
Free

Add this comparison widget to your blog or website:

<a href="https://stockvs.app/ABBV/vs/NVS" target="_blank" rel="noopener noreferrer" style="display: inline-flex; align-items: center; gap: 8px; padding: 8px 16px; background: linear-gradient(135deg, #3b82f6, #8b5cf6); color: white; text-decoration: none; border-radius: 8px; font-family: system-ui, sans-serif; font-size: 14px; font-weight: 500;">
  <svg width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M18 20V10"/><path d="M12 20V4"/><path d="M6 20v-6"/></svg>
  Compare ABBV vs NVS on stockvs.app
</a>